Clinical Validation of New OCT System

Exclusion Criteria

• •1. Subjects unable to tolerate ophthalmic imaging
• •2. Subject with ocular media not sufficiently clear to obtain acceptable OCT images
• •3. HFA visual field (24-2 Sita Standard, white on white) result abnormal, defined as GHT 'Outside Normal Limits' and/or PSD \< 1%
• •4. HFA visual field (24-2 Sita Standard, white on white) result unreliable (based on manufacturer's recommendation), defined as fixation losses \> 33% or false positives \> 25%, or false negatives \> 25%
• •5. Presence of any ocular pathology except for cataract
• •6. Previous ocular surgery or laser treatment other than uncomplicated refractive procedure or cataract surgery performed within six months prior to study scanning
• •7. Narrow angle
• •8. History of leukemia, dementia or multiple sclerosis
• •9. Concomitant use of hydroxychloroquine and chloroquine
• •1. Subjects unable to tolerate ophthalmic imaging
• •2. Subject with ocular media not sufficiently clear to obtain acceptable OCT images
• •3. HFA visual field (24-2 Sita Standard, white on white) result unreliable, defined as fixation losses \> 33% or false positives \> 25%, or false negatives \> 25% in the study eye
• •4. Presence of any ocular pathology except glaucoma in the study eye
• •5. Previous ocular surgery or laser treatment other than uncomplicated procedures performed within six months prior to study scanning in the study eye
• •6. History of leukemia, dementia or multiple sclerosis
• •7. Concomitant use of hydroxychloroquine and chloroquine
• •1. Subjects unable to tolerate ophthalmic imaging
• •2. Subject with ocular media not sufficiently clear to obtain acceptable OCT images
• •3. Presence of glaucoma or any ocular pathology other than a Retinal pathology (e.g., cornea pathology) in the study eye
• •4. Previous ocular surgery or laser treatment other than uncomplicated procedures performed within six months prior to study scanning in the study eye
• •5. Narrow angle in the study eye
• •6. History of leukemia, dementia or multiple sclerosis
• •7. Concomitant use of hydroxychloroquine and chloroquine